Davis's Drug Guide
tepotinib
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
Pronunciation:
tep-oh-ti-nib
Trade Name(s)
- Tepmetko
Ther. Class.
Pharm. Class.
kinase inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Tepotinib." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580098/all/tepotinib.
Vallerand AHA, Sanoski CAC, . Tepotinib. Davis's Drug Guide. F.A. Davis Company; 2025. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580098/all/tepotinib. Accessed April 16, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Tepotinib. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580098/all/tepotinib
Vallerand AHA, Sanoski CAC, . Tepotinib [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 April 16]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580098/all/tepotinib.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - tepotinib
ID - 3580098
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580098/all/tepotinib
PB - F.A. Davis Company
ET - 19
DB - Anesthesia Central
DP - Unbound Medicine
ER -
